ARDIS

Related by string. Ardis . Ardi . ARDI * * Ardi Rizal . Ardi hominid . Dr. Ardis Hoven . Road ARDI Business.com . Ardis Baad . Ardis Watkins . Inc. Nasdaq ARDI . NASDAQ ARDI . Jim Ardis . nicknamed Ardi . Ardi Kolah . Ardis Krainik . Ardis Jaculina . Ardis Baad Staff Writer . Road ARDI *

Related by context. Frequent words. (Click for all words.) 63 Phase 2a trial 62 Phase 2b study 62 Phase 2b trial 61 ATTRACT 61 phase IIb 61 Phase 2a clinical 61 Phase 1b 59 dose escalation trial 59 Phase Ib 59 Phase IIb clinical 58 Phase Ia 58 phase IIa 58 confirmatory Phase III 58 Phase 2b clinical 58 Phase III pivotal 58 Phase 2a 57 placebo controlled randomized 57 Phase 1b clinical 57 Phase 2b 57 pivotal Phase 57 multicenter randomized double 57 phase 2a 57 pivotal Phase III 57 randomized Phase III 57 Phase 1b trial 56 Phase IIb trial 56 PROPEL 56 Phase 1a 56 Phase IIa trial 56 multicentre 56 Phase III randomized 56 Phase IIa clinical 55 dose escalation 55 Phase III clinical 54 ARIES 54 PROMACTA 54 Phase IIa 54 randomized Phase 54 label dose escalation 54 DURATION 54 Phase IIb 54 INFORM 53 placebo controlled 53 axitinib 53 PF # [001] 53 active comparator 53 investigational compounds 53 multicenter clinical 53 CAPACITY 53 Phenoptin 53 PS# [001] 53 PREOS 53 dose cohorts 52 DSMB 52 multicenter 52 dose escalation study 52 blind randomized placebo 52 REPLACE 52 Initiates Phase 52 Phase 52 RG# [001] 52 denufosol 52 Phase III 52 randomized controlled 52 INCB# [002] 52 randomized placebo controlled 52 tolerated dose MTD 52 vicriviroc 52 MAESTRO 51 ACHIEVE 51 CoFactor 51 elagolix 51 randomized double 51 clinical trial 51 ofatumumab 51 ZYBRESTAT 51 methylnaltrexone 51 unblinded 51 safety tolerability pharmacokinetics 51 substudy 51 confirmatory Phase 3 51 belinostat 51 Amigal 51 multiple ascending dose 51 ISIS # 51 prospective randomized 51 NUVIGIL 51 single ascending dose 50 STELLAR 50 ISENTRESS 50 ocrelizumab 50 mipomersen 50 BAY #-# 50 TRIUMPH 50 sNDA 50 tesmilifene 50 sapacitabine 50 COPAXONE R 50 TELCYTA 50 investigational oral 50 EORTC

Back to home page